Meningococcemia is a serious disease caused by the bacterium Neisseria meningitidis. It invades the bloodstream, affecting the whole body by causing coagulation disorders and shock (lack of blood flow which leads to a lack of oxygen and nutrients in cells and organs to function properly). It is transmitted by drops from an infected individual through breathing, sneezing and/or coughing. There may be few symptoms (fever, headache, irritability, muscle pain, nausea, skin rash with red/purple patches or petechiae), with the delayed symptoms being impaired consciousness, areas of bleeding under the skin and shock. The diagnosis is made through the medical history, a physical examination, laboratory tests and cerebrospinal fluid analysis, cultures, skin lesion biopsy, etc. It requires urgent admission to an intensive care unit, respiratory isolation and treatment to be started early.
- Michael Apicella. Clinical manifestations of meningococcal infection. UpToDate. Sep 03, 2015.
- Michael Apicella. Treatment and prevention of meningococcal infection. UpToDate. Jul 15, 2015.
- Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1.
- Tunkel AR, van de Beek D, Scheld WM. Acute meningitis. In: Principles and Practice of Infectious Diseases, 7th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2010. p.1189.
- Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369:2196.
- Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006; 367:397.
- Stephens DS y cols. Infecciones por meningococos y Listerias. Harrison. Manual de Medicina. 16º edición. 488-490.
- Mayra Gómez Moreno, Cristina Domínguez, Verónica Odriozola. Manual de diagnóstico y terapéutica médica Hospital Universitario 12 de octubre. 6º edición. 2007. 482: 485.

